A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO) (2017) Sehouli J, Tome O, Dimitrova D, Camara O, Runnebaum IB, Tessen HW, Rautenberg B, et al. Journal article Functional analyses and prognostic significance of SFRP1 expression in bladder cancer (2015) Rogler A, Kendziorra E, Giedl J, Stoehr C, Taubert H, Goebell P, Wullich B, et al. Journal article Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy (2015) Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, et al. Journal article Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients (2013) Heilmann T, Mathiak M, Hofmann J, Mundhenke C, Van Mackelenbergh M, Alkatout I, Wenners A, et al. Journal article Everolimus as treatment for breast cancer patients with bone metastases only: Results of the phase II RADAR study (2013) Maass N, Harbeck N, Mundhenke C, Lerchenmueller C, Barinoff J, Lueck HJ, Ettl J, et al. Journal article Diabetes and prognosis in a breast cancer cohort (2011) Schrauder M, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, et al. Journal article Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer (2008) Schrauder M, Frank S, Strissel P, Lux MP, Bani M, Rauh C, Sieber C, et al. Journal article